Table 4.
Energy Variation | Hyperpitch | Formants | Pitch | Voicing | ||||||
---|---|---|---|---|---|---|---|---|---|---|
CpG Position | rho | p | rho | p | rho | p | rho | p | rho | p |
(A) CRY UTTERANCE 1 | ||||||||||
Mean# | −0.292 | 0.002* | 0.094 | 0.320 | 0.060 | 0.520 | −0.150 | 0.110 | −0.002 | 0.990 |
Position 1 | −0.485 | <0.001* | 0.306 | <0.001* | −0.261 | 0.005* | −0.011 | 0.910 | 0.195 | 0.037* |
Position 2 | −0.469 | <0.001* | 0.314 | <0.001* | −0.097 | 0.304 | −0.091 | 0.330 | 0.177 | 0.059 |
Position 3 | −0.342 | <0.001* | 0.308 | <0.001* | −0.115 | 0.222 | −0.208 | 0.027* | 0.227 | 0.015* |
Position 4 | −0.393 | <0.001* | 0.223 | 0.017* | −0.106 | 0.261 | −0.015 | 0.877 | 0.062 | 0.515 |
(B) CRY UTTERANCE 2 | ||||||||||
Mean# | −0.206 | 0.028* | 0.051 | 0.590 | −0.087 | 0.356 | −0.276 | 0.003* | 0.016 | 0.865 |
Position 1 | −0.358 | <0.001* | 0.360 | <0.001* | 0.007 | 0.944 | −0.179 | 0.056 | 0.167 | 0.075 |
Position 2 | −0.248 | 0.008* | 0.269 | 0.004* | −0.042 | 0.659 | −0.162 | 0.085 | 0.191 | 0.042* |
Position 3 | −0.207 | 0.027* | 0.120 | 0.202 | −0.008 | 0.936 | −0.154 | 0.101 | 0.197 | 0.036* |
Position 4 | −0.190 | 0.043* | 0.129 | 0.172 | 0.128 | 0.175 | −0.155 | 0.100 | 0.075 | 0.429 |
(C) CRY UTTERANCE 3 | ||||||||||
Mean# | −0.300 | 0.002* | −0.202 | 0.037 | −0.115 | 0.237 | −0.079 | 0.417 | ||
Position 1 | −0.418 | <0.001* | −0.274 | 0.004* | −0.102 | 0.296 | 0.235 | 0.015* | ||
Position 2 | −0.362 | <0.001* | −0.163 | 0.093 | −0.808 | 0.412 | 0.331 | 0.001* | ||
Position 3 | −0.334 | <0.001* | −0.236 | 0.014* | −0.077 | 0.429 | 0.117 | 0.232 | ||
Position 4 | −0.302 | 0.002* | −0.215 | 0.026* | −0.019 | 0.847 | 0.074 | 0.449 |
Mean methylation across all 13 NR3C1 CpG sites. Values in bold and with an asterisk are significant at q < 0.10, FDR threshold (14 tests for the mean methylation findings and 56 tests for CpG sites 1 to 4 in relation to cry utterances 1, 2, and 3).